+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
AI Medical Imaging Software for Cardiovascular Disease Market - Global Forecast 2026-2032- Product Image
AI Medical Imaging Software for Cardiovascular Disease Market - Global Forecast 2026-2032- Product Image
Sale

AI Medical Imaging Software for Cardiovascular Disease Market - Global Forecast 2026-2032

  • Report

  • 193 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6125578
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The AI Medical Imaging Software for Cardiovascular Disease Market is projected to reach USD 2.56 Billion in 2026. It is expected to continue growing at a CAGR of 10.85%, reaching USD 4.94 Billion by 2032.

AI Medical Imaging Software for Cardiovascular Disease: Executive Overview

AI medical imaging software for cardiovascular disease supports the interpretation, triage, quantification, and longitudinal review of modalities such as echocardiography, computed tomography, magnetic resonance imaging, and radiography. Its clinical value is strongest when it complements specialist judgment, improves consistency, and helps care teams identify clinically relevant findings earlier. Adoption depends on validated performance, workflow integration, cybersecurity, interoperability, and clear accountability for human oversight.

From Standalone Algorithms to Integrated Cardiovascular Workflows

The landscape is shifting from isolated image-analysis tools toward interoperable platforms embedded in diagnostic and care pathways. Greater emphasis is being placed on automated measurements, structured reporting, multimodality review, longitudinal comparison, and prioritization of urgent studies. These shifts are also increasing the importance of representative training data, transparent validation, post-deployment monitoring, and integration with electronic health records and imaging archives.

Artificial Intelligence Extends Capacity but Does Not Replace Clinical Judgment

Artificial intelligence can reduce repetitive measurement, flag potentially significant findings, support image quality assessment, and help standardize interpretation across sites. Its cumulative impact is shaped by data quality, prevalence differences, workflow design, and the ability of clinicians to recognize uncertainty or model failure. Effective deployment therefore combines algorithmic assistance with prospective validation, human review, bias assessment, audit trails, and continuous performance surveillance.

Regional Priorities Differ Across North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific

North America generally emphasizes clinical validation, regulated deployment, interoperability, and integration into established cardiovascular services. Europe places strong weight on data governance, medical-device compliance, cross-border privacy, and health-system compatibility. Asia-Pacific combines advanced hospital adoption in selected markets with substantial variation in infrastructure, workforce capacity, and access. Latin America is shaped by uneven digital maturity and the need for scalable tools that function across diverse provider settings. The Middle East is characterized by investment in digitally enabled care and specialist services, while Africa faces infrastructure, connectivity, workforce, and data-representation constraints that make resilient and context-sensitive implementation essential.

ASEAN, BRICS, the European Union, G7, GCC, and NATO Reveal Different Adoption Conditions

ASEAN countries face varied regulatory, infrastructure, and language environments, encouraging interoperable and adaptable solutions. BRICS members reflect wide differences in health-system capacity, domestic data policy, and specialist availability, making local validation important. The European Union is influenced by harmonized regulatory and privacy requirements alongside cross-border interoperability goals. G7 members typically have mature clinical research and digital-health ecosystems but must address integration, evidence, and workforce concerns. GCC systems often prioritize centralized modernization and advanced diagnostic capability, whereas NATO members must also consider resilience, cybersecurity, and continuity of healthcare operations.

Country-Level Implementation Depends on Infrastructure, Regulation, and Clinical Capacity

Australia and Canada require solutions suited to geographically dispersed care and strong privacy expectations. Brazil, Mexico, India, and South Africa benefit from tools that can support heterogeneous facilities, connectivity conditions, and specialist access. China, Japan, and South Korea combine significant technical capability with distinctive regulatory, procurement, and data-governance requirements. France, Germany, Italy, Spain, and the United Kingdom require alignment with national or regional health-system processes, clinical evidence expectations, and privacy rules. The United States has a broad environment for regulated clinical AI but demands careful attention to reimbursement, liability, interoperability, and real-world monitoring. Russia’s deployment context is shaped by local regulatory, infrastructure, and data-access considerations.

Prioritize Evidence, Interoperability, Equity, and Safe Workflow Integration

Industry leaders should begin with clearly defined cardiovascular use cases and measurable clinical or operational endpoints rather than broad automation goals. They should validate performance across modalities, demographics, care settings, and disease presentations; establish human-in-the-loop governance; and monitor performance after deployment. Interoperability with imaging archives, reporting systems, and electronic records should be treated as a core product requirement. Leaders should also strengthen cybersecurity, document limitations, involve clinicians and patients in workflow design, and create procurement and training practices that prevent widening disparities between well-resourced and underserved facilities.

Evidence-Based Methodology for Assessing the Cardiovascular Imaging Software Landscape

This executive summary uses a structured qualitative assessment of the specified market domain, organized around technology capabilities, clinical workflows, regulatory conditions, infrastructure, and implementation requirements. The analysis compares geographic and country contexts using publicly established characteristics of healthcare delivery, digital maturity, data governance, and cardiovascular service capacity. It intentionally excludes market estimates, market sizing, market shares, forecasts, and company-specific analysis. Conclusions should be tested against current regulatory documents, peer-reviewed validation studies, procurement requirements, and local clinical evidence before operational decisions are made.

Responsible Integration Will Define the Next Phase of Cardiovascular Imaging AI

AI medical imaging software can improve consistency, prioritize attention, and extend specialist capacity when it is deployed as a clinically governed component of care. The strongest pathways to value combine robust evidence, interoperable infrastructure, representative data, transparent limitations, and continuous oversight. Regional and country differences mean that successful implementation will depend less on a single universal model than on adaptable solutions aligned with local regulation, workflows, resources, and patient needs.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. AI Medical Imaging Software for Cardiovascular Disease Market, by Technology
7.1. Introduction
7.2. Computer Vision
7.3. Deep Learning
7.3.1. Convolutional Neural Network
7.3.2. Generative Adversarial Network
7.3.3. Recurrent Neural Network
7.4. Machine Learning
7.4.1. Decision Tree
7.4.2. Random Forest
7.4.3. Support Vector Machine
7.5. Natural Language Processing
8. AI Medical Imaging Software for Cardiovascular Disease Market, by Imaging Modality
8.1. Introduction
8.2. CT
8.2.1. CT Angiography
8.2.2. CT Perfusion
8.3. Echocardiography
8.3.1. 2D Echo
8.3.2. 3D Echo
8.3.3. Doppler Echo
8.4. Fluoroscopy
8.5. MRI
8.5.1. Cardiac MRI
8.5.2. MR Angiography
8.6. X Ray
9. AI Medical Imaging Software for Cardiovascular Disease Market, by Deployment Mode
9.1. Introduction
9.2. Cloud
9.2.1. Hybrid Cloud
9.2.2. Private Cloud
9.2.3. Public Cloud
9.3. On Premise
9.3.1. Appliance Based
9.3.2. Server Based
10. AI Medical Imaging Software for Cardiovascular Disease Market, by Application
10.1. Introduction
10.2. Arrhythmia
10.3. Congenital Heart Disease
10.4. Coronary Artery Disease
10.5. Heart Failure
10.6. Valvular Disease
11. AI Medical Imaging Software for Cardiovascular Disease Market, by End User
11.1. Introduction
11.2. Ambulatory Clinics
11.3. Diagnostic Centers
11.4. Hospitals
11.5. Research Institutes
12. AI Medical Imaging Software for Cardiovascular Disease Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. AI Medical Imaging Software for Cardiovascular Disease Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. AI Medical Imaging Software for Cardiovascular Disease Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Aidoc Medical Ltd.
16.2. Arterys, Inc.
16.3. Canon Medical Systems Corporation
16.4. CureMetrix Inc.
16.5. Densitas Inc.
16.6. eCure Corp.
16.7. GE HealthCare Technologies Inc.
16.8. HeartFlow, Inc.
16.9. Koninklijke Philips N.V.
16.10. LifeBlood Analytics Ltd.
16.11. Lunit Inc.
16.12. Medis Medical Imaging Systems B.V.
16.13. Quibim SL
16.14. Qure.ai Technologies Pvt. Ltd.
16.15. Siemens Healthineers AG
16.16. Ultromics Ltd.
16.17. VIDA Diagnostics, Inc.
16.18. Viz.ai, Inc.
16.19. Zebra Medical Vision Ltd.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global AI Medical Imaging Software for Cardiovascular Disease Market, Years Considered for the Study
FIGURE 2. Global AI Medical Imaging Software for Cardiovascular Disease Market, Research Design
FIGURE 3. Global AI Medical Imaging Software for Cardiovascular Disease Market, Research Framework
FIGURE 4. Global AI Medical Imaging Software for Cardiovascular Disease Market, Data Triangulation
FIGURE 5. Global AI Medical Imaging Software for Cardiovascular Disease Market Size, 2017-2032 (USD Million)
FIGURE 6. Global AI Medical Imaging Software for Cardiovascular Disease Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 7. Global AI Medical Imaging Software for Cardiovascular Disease Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global AI Medical Imaging Software for Cardiovascular Disease Market Size, by Imaging Modality, 2025 vs 2032 (%)
FIGURE 9. Global AI Medical Imaging Software for Cardiovascular Disease Market Size, by Imaging Modality, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global AI Medical Imaging Software for Cardiovascular Disease Market Size, by Deployment Mode, 2025 vs 2032 (%)
FIGURE 11. Global AI Medical Imaging Software for Cardiovascular Disease Market Size, by Deployment Mode, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global AI Medical Imaging Software for Cardiovascular Disease Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global AI Medical Imaging Software for Cardiovascular Disease Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global AI Medical Imaging Software for Cardiovascular Disease Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global AI Medical Imaging Software for Cardiovascular Disease Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global AI Medical Imaging Software for Cardiovascular Disease Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global AI Medical Imaging Software for Cardiovascular Disease Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global AI Medical Imaging Software for Cardiovascular Disease Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global AI Medical Imaging Software for Cardiovascular Disease Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global AI Medical Imaging Software for Cardiovascular Disease Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global AI Medical Imaging Software for Cardiovascular Disease Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global AI Medical Imaging Software for Cardiovascular Disease Market Segmentation & Coverage
TABLE 2. Global AI Medical Imaging Software for Cardiovascular Disease Market Size, 2017-2032 (USD Million)
TABLE 3. Global AI Medical Imaging Software for Cardiovascular Disease Market Size, by Technology, 2017-2032 (USD Million)
TABLE 4. Global Computer Vision Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Computer Vision Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Computer Vision Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Deep Learning Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Deep Learning Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Deep Learning Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Convolutional Neural Network Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Convolutional Neural Network Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Convolutional Neural Network Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Generative Adversarial Network Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Generative Adversarial Network Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Generative Adversarial Network Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Recurrent Neural Network Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Recurrent Neural Network Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Recurrent Neural Network Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Machine Learning Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Machine Learning Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Machine Learning Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Decision Tree Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Decision Tree Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Decision Tree Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Random Forest Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Random Forest Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Random Forest Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Support Vector Machine Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Support Vector Machine Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Support Vector Machine Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Natural Language Processing Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Natural Language Processing Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Natural Language Processing Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global AI Medical Imaging Software for Cardiovascular Disease Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 35. Global CT Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global CT Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global CT Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global CT Angiography Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global CT Angiography Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global CT Angiography Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global CT Perfusion Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global CT Perfusion Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global CT Perfusion Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Echocardiography Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Echocardiography Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Echocardiography Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global 2D Echo Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global 2D Echo Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global 2D Echo Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global 3D Echo Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global 3D Echo Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global 3D Echo Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Doppler Echo Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Doppler Echo Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Doppler Echo Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Fluoroscopy Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Fluoroscopy Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Fluoroscopy Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global MRI Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global MRI Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global MRI Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Cardiac MRI Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Cardiac MRI Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Cardiac MRI Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global MR Angiography Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global MR Angiography Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global MR Angiography Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global X Ray Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global X Ray Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global X Ray Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global AI Medical Imaging Software for Cardiovascular Disease Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 72. Global Cloud Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Cloud Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Cloud Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Hybrid Cloud Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Hybrid Cloud Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Hybrid Cloud Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Private Cloud Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Private Cloud Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Private Cloud Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Public Cloud Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Public Cloud Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Public Cloud Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global On Premise Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global On Premise Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global On Premise Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global Appliance Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global Appliance Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global Appliance Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global Server Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Global Server Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. Global Server Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 93. Global AI Medical Imaging Software for Cardiovascular Disease Market Size, by Application, 2017-2032 (USD Million)
TABLE 94. Global Arrhythmia Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Global Arrhythmia Market Size, by Group, 2017-2032 (USD Million)
TABLE 96. Global Arrhythmia Market Size, by Country, 2017-2032 (USD Million)
TABLE 97. Global Congenital Heart Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global Congenital Heart Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global Congenital Heart Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global Coronary Artery Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Global Coronary Artery Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. Global Coronary Artery Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 103. Global Heart Failure Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Global Heart Failure Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. Global Heart Failure Market Size, by Country, 2017-2032 (USD Million)
TABLE 106. Global Valvular Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Global Valvular Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 108. Global Valvular Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 109. Global AI Medical Imaging Software for Cardiovascular Disease Market Size, by End User, 2017-2032 (USD Million)
TABLE 110. Global Ambulatory Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 111. Global Ambulatory Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 112. Global Ambulatory Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 113. Global Diagnostic Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. Global Diagnostic Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 115. Global Diagnostic Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 116. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 117. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 118. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 119. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 120. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 121. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 122. Global AI Medical Imaging Software for Cardiovascular Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 123. Asia-Pacific AI Medical Imaging Software for Cardiovascular Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 124. Asia-Pacific AI Medical Imaging Software for Cardiovascular Disease Market Size, by Technology, 2017-2032 (USD Million)
TABLE 125. Asia-Pacific AI Medical Imaging Software for Cardiovascular Disease Market Size, by Deep Learning, 2017-2032 (USD Million)
TABLE 126. Asia-Pacific AI Medical Imaging Software for Cardiovascular Disease Market Size, by Machine Learning, 2017-2032 (USD Million)
TABLE 127. Asia-Pacific AI Medical Imaging Software for Cardiovascular Disease Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 128. Asia-Pacific AI Medical Imaging Software for Cardiovascular Disease Market Size, by CT, 2017-2032 (USD Million)
TABLE 129. Asia-Pacific AI Medical Imaging Software for Cardiovascular Disease Market Size, by Echocardiography, 2017-2032 (USD Million)
TABLE 130. Asia-Pacific AI Medical Imaging Software for Cardiovascular Disease Market Size, by MRI, 2017-2032 (USD Million)
TABLE 131. Asia-Pacific AI Medical Imaging Software for Cardiovascular Disease Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 132. Asia-Pacific AI Medical Imaging Software for Cardiovascular Disease Market Size, by Cloud, 2017-2032 (USD Million)
TABLE 133. Asia-Pacific AI Medical Imaging Software for Cardiovascular Disease Market Size, by On Premise, 2017-2032 (USD Million)
TABLE 134. Asia-Pacific AI Medical Imaging Software for Cardiovascular Disease Market Size, by Application, 2017-2032 (USD Million)
TABLE 135. Asia-Pacific AI Medical Imaging Software for Cardiovascular Disease Market Size, by End User, 2017-2032 (USD Million)
TABLE 136. North America AI Medical Imaging Software for Cardiovascular Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 137. North America AI Medical Imaging Software for Cardiovascular Disease Market Size, by Technology, 2017-2032 (USD Million)
TABLE 138. North America AI Medical Imaging Software for Cardiovascular Disease Market Size, by Deep Learning, 2017-2032 (USD Million)
TABLE 139. North America AI Medical Imaging Software for Cardiovascular Disease Market Size, by Machine Learning, 2017-2032 (USD Million)
TABLE 140. North America AI Medical Imaging Software for Cardiovascular Disease Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 141. North America AI Medical Imaging Software for Cardiovascular Disease Market Size, by CT, 2017-2032 (USD Million)
TABLE 142. North America AI Medical Imaging Software for Cardiovascular Disease Market Size, by Echocardiography, 2017-2032 (USD Million)
TABLE 143. North America AI Medical Imaging Software for Cardiovascular Disease Market Size, by MRI, 2017-2032 (USD Million)
TABLE 144. North America AI Medical Imaging Software for Cardiovascular Disease Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 145. North America AI Medical Imaging Software for Cardiovascular Disease Market Size, by Cloud, 2017-2032 (USD Million)
TABLE 146. North America AI Medical Imaging Software for Cardiovascular Disease Market Size, by On Premise, 2017-2032 (USD Million)
TABLE 147. North America AI Medical Imaging Software for Cardiovascular Disease Market Size, by Application, 2017-2032 (USD Million)
TABLE 148. North America AI Medical Imaging Software for Cardiovascular Disease Market Size, by End User, 2017-2032 (USD Million)
TABLE 149. Latin America AI Medical Imaging Software for Cardiovascular Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 150. Latin America AI Medical Imaging Software for Cardiovascular Disease Market Size, by Technology, 2017-2032 (USD Million)
TABLE 151. Latin America AI Medical Imaging Software for Cardiovascular Disease Market Size, by Deep Learning, 2017-2032 (USD Million)
TABLE 152. Latin America AI Medical Imaging Software for Cardiovascular Disease Market Size, by Machine Learning, 2017-2032 (USD Million)
TABLE 153. Latin America AI Medical Imaging Software for Cardiovascular Disease Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 154. Latin America AI Medical Imaging Software for Cardiovascular Disease Market Size, by CT, 2017-2032 (USD Million)
TABLE 155. Latin America AI Medical Imaging Software for Cardiovascular Disease Market Size, by Echocardiography, 2017-2032 (USD Million)
TABLE 156. Latin America AI Medical Imaging Software for Cardiovascular Disease Market Size, by MRI, 2017-2032 (USD Million)
TABLE 157. Latin America AI Medical Imaging Software for Cardiovascular Disease Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 158. Latin America AI Medical Imaging Software for Cardiovascular Disease Market Size, by Cloud, 2017-2032 (USD Million)
TABLE 159. Latin America AI Medical Imaging Software for Cardiovascular Disease Market Size, by On Premise, 2017-2032 (USD Million)
TABLE 160. Latin America AI Medical Imaging Software for Cardiovascular Disease Market Size, by Application, 2017-2032 (USD Million)
TABLE 161. Latin America AI Medical Imaging Software for Cardiovascular Disease Market Size, by End User, 2017-2032 (USD Million)
TABLE 162. Europe AI Medical Imaging Software for Cardiovascular Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 163. Europe AI Medical Imaging Software for Cardiovascular Disease Market Size, by Technology, 2017-2032 (USD Million)
TABLE 164. Europe AI Medical Imaging Software for Cardiovascular Disease Market Size, by Deep Learning, 2017-2032 (USD Million)
TABLE 165. Europe AI Medical Imaging Software for Cardiovascular Disease Market Size, by Machine Learning, 2017-2032 (USD Million)
TABLE 166. Europe AI Medical Imaging Software for Cardiovascular Disease Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 167. Europe AI Medical Imaging Software for Cardiovascular Disease Market Size, by CT, 2017-2032 (USD Million)
TABLE 168. Europe AI Medical Imaging Software for Cardiovascular Disease Market Size, by Echocardiography, 2017-2032 (USD Million)
TABLE 169. Europe AI Medical Imaging Software for Cardiovascular Disease Market Size, by MRI, 2017-2032 (USD Million)
TABLE 170. Europe AI Medical Imaging Software for Cardiovascular Disease Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 171. Europe AI Medical Imaging Software for Cardiovascular Disease Market Size, by Cloud, 2017-2032 (USD Million)
TABLE 172. Europe AI Medical Imaging Software for Cardiovascular Disease Market Size, by On Premise, 2017-2032 (USD Million)
TABLE 173. Europe AI Medical Imaging Software for Cardiovascular Disease Market Size, by Application, 2017-2032 (USD Million)
TABLE 174. Europe AI Medical Imaging Software for Cardiovascular Disease Market Size, by End User, 2017-2032 (USD Million)
TABLE 175. Middle East AI Medical Imaging Software for Cardiovascular Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 176. Middle East AI Medical Imaging Software for Cardiovascular Disease Market Size, by Technology, 2017-2032 (USD Million)
TABLE 177. Middle East AI Medical Imaging Software for Cardiovascular Disease Market Size, by Deep Learning, 2017-2032 (USD Million)
TABLE 178. Middle East AI Medical Imaging Software for Cardiovascular Disease Market Size, by Machine Learning, 2017-2032 (USD Million)
TABLE 179. Middle East AI Medical Imaging Software for Cardiovascular Disease Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 180. Middle East AI Medical Imaging Software for Cardiovascular Disease Market Size, by CT, 2017-2032 (USD Million)
TABLE 181. Middle East AI Medical Imaging Software for Cardiovascular Disease Market Size, by Echocardiography, 2017-2032 (USD Million)
TABLE 182. Middle East AI Medical Imaging Software for Cardiovascular Disease Market Size, by MRI, 2017-2032 (USD Million)
TABLE 183. Middle East AI Medical Imaging Software for Cardiovascular Disease Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 184. Middle East AI Medical Imaging Software for Cardiovascular Disease Market Size, by Cloud, 2017-2032 (USD Million)
TABLE 185. Middle East AI Medical Imaging Software for Cardiovascular Disease Market Size, by On Premise, 2017-2032 (USD Million)
TABLE 186. Middle East AI Medical Imaging Software for Cardiovascular Disease Market Size, by Application, 2017-2032 (USD Million)
TABLE 187. Middle East AI Medical Imaging Software for Cardiovascular Disease Market Size, by End User, 2017-2032 (USD Million)
TABLE 188. Africa AI Medical Imaging Software for Cardiovascular Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 189. Africa AI Medical Imaging Software for Cardiovascular Disease Market Size, by Technology, 2017-2032 (USD Million)
TABLE 190. Africa AI Medical Imaging Software for Cardiovascular Disease Market Size, by Deep Learning, 2017-2032 (USD Million)
TABLE 191. Africa AI Medical Imaging Software for Cardiovascular Disease Market Size, by Machine Learning, 2017-2032 (USD Million)
TABLE 192. Africa AI Medical Imaging Software for Cardiovascular Disease Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 193. Africa AI Medical Imaging Software for Cardiovascular Disease Market Size, by CT, 2017-2032 (USD Million)
TABLE 194. Africa AI Medical Imaging Software for Cardiovascular Disease Market Size, by Echocardiography, 2017-2032 (USD Million)
TABLE 195. Africa AI Medical Imaging Software for Cardiovascular Disease Market Size, by MRI, 2017-2032 (USD Million)
TABLE 196. Africa AI Medical Imaging Software for Cardiovascular Disease Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 197. Africa AI Medical Imaging Software for Cardiovascular Disease Market Size, by Cloud, 2017-2032 (USD Million)
TABLE 198. Africa AI Medical Imaging Software for Cardiovascular Disease Market Size, by On Premise, 2017-2032 (USD Million)
TABLE 199. Africa AI Medical Imaging Software for Cardiovascular Disease Market Size, by Application, 2017-2032 (USD Million)
TABLE 200. Africa AI Medical Imaging Software for Cardiovascular Disease Market Size, by End User, 2017-2032 (USD Million)
TABLE 201. Global AI Medical Imaging Software for Cardiovascular Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 202. ASEAN AI Medical Imaging Software for Cardiovascular Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 203. ASEAN AI Medical Imaging Software for Cardiovascular Disease Market Size, by Technology, 2017-2032 (USD Million)
TABLE 204. ASEAN AI Medical Imaging Software for Cardiovascular Disease Market Size, by Deep Learning, 2017-2032 (USD Million)
TABLE 205. ASEAN AI Medical Imaging Software for Cardiovascular Disease Market Size, by Machine Learning, 2017-2032 (USD Million)
TABLE 206. ASEAN AI Medical Imaging Software for Cardiovascular Disease Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 207. ASEAN AI Medical Imaging Software for Cardiovascular Disease Market Size, by CT, 2017-2032 (USD Million)
TABLE 208. ASEAN AI Medical Imaging Software for Cardiovascular Disease Market Size, by Echocardiography, 2017-2032 (USD Million)
TABLE 209. ASEAN AI Medical Imaging Software for Cardiovascular Disease Market Size, by MRI, 2017-2032 (USD Million)
TABLE 210. ASEAN AI Medical Imaging Software for Cardiovascular Disease Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 211. ASEAN AI Medical Imaging Software for Cardiovascular Disease Market Size, by Cloud, 2017-2032 (USD Million)
TABLE 212. ASEAN AI Medical Imaging Software for Cardiovascular Disease Market Size, by On Premise, 2017-2032 (USD Million)
TABLE 213. ASEAN AI Medical Imaging Software for Cardiovascular Disease Market Size, by Application, 2017-2032 (USD Million)
TABLE 214. ASEAN AI Medical Imaging Software for Cardiovascular Disease Market Size, by End User, 2017-2032 (USD Million)
TABLE 215. GCC AI Medical Imaging Software for Cardiovascular Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 216. GCC AI Medical Imaging Software for Cardiovascular Disease Market Size, by Technology, 2017-2032 (USD Million)
TABLE 217. GCC AI Medical Imaging Software for Cardiovascular Disease Market Size, by Deep Learning, 2017-2032 (USD Million)
TABLE 218. GCC AI Medical Imaging Software for Cardiovascular Disease Market Size, by Machine Learning, 2017-2032 (USD Million)
TABLE 219. GCC AI Medical Imaging Software for Cardiovascular Disease Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 220. GCC AI Medical Imaging Software for Cardiovascular Disease Market Size, by CT, 2017-2032 (USD Million)
TABLE 221. GCC AI Medical Imaging Software for Cardiovascular Disease Market Size, by Echocardiography, 2017-2032 (USD Million)
TABLE 222. GCC AI Medical Imaging Software for Cardiovascular Disease Market Size, by MRI, 2017-2032 (USD Million)
TABLE 223. GCC AI Medical Imaging Software for Cardiovascular Disease Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 224. GCC AI Medical Imaging Software for Cardiovascular Disease Market Size, by Cloud, 2017-2032 (USD Million)
TABLE 225. GCC AI Medical Imaging Software for Cardiovascular Disease Market Size, by On Premise, 2017-2032 (USD Million)
TABLE 226. GCC AI Medical Imaging Software for Cardiovascular Disease Market Size, by Application, 2017-2032 (USD Million)
TABLE 227. GCC AI Medical Imaging Software for Cardiovascular Disease Market Size, by End User, 2017-2032 (USD Million)
TABLE 228. European Union AI Medical Imaging Software for Cardiovascular Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 229. European Union AI Medical Imaging Software for Cardiovascular Disease Market Size, by Technology, 2017-2032 (USD Million)
TABLE 230. European Union AI Medical Imaging Software for Cardiovascular Disease Market Size, by Deep Learning, 2017-2032 (USD Million)
TABLE 231. European Union AI Medical Imaging Software for Cardiovascular Disease Market Size, by Machine Learning, 2017-2032 (USD Million)
TABLE 232. European Union AI Medical Imaging Software for Cardiovascular Disease Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 233. European Union AI Medical Imaging Software for Cardiovascular Disease Market Size, by CT, 2017-2032 (USD Million)
TABLE 234. European Union AI Medical Imaging Software for Cardiovascular Disease Market Size, by Echocardiography, 2017-2032 (USD Million)
TABLE 235. European Union AI Medical Imaging Software for Cardiovascular Disease Market Size, by MRI, 2017-2032 (USD Million)
TABLE 236. European Union AI Medical Imaging Software for Cardiovascular Disease Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 237. European Union AI Medical Imaging Software for Cardiovascular Disease Market Size, by Cloud, 2017-2032 (USD Million)
TABLE 238. European Union AI Medical Imaging Software for Cardiovascular Disease Market Size, by On Premise, 2017-2032 (USD Million)
TABLE 239. European Union AI Medical Imaging Software for Cardiovascular Disease Market Size, by Application, 2017-2032 (USD Million)
TABLE 240. European Union AI Medical Imaging Software for Cardiovascular Disease Market Size, by End User, 2017-2032 (USD Million)
TABLE 241. BRICS AI Medical Imaging Software for Cardiovascular Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 242. BRICS AI Medical Imaging Software for Cardiovascular Disease Market Size, by Technology, 2017-2032 (USD Million)
TABLE 243. BRICS AI Medical Imaging Software for Cardiovascular Disease Market Size, by Deep Learning, 2017-2032 (USD Million)
TABLE 244. BRICS AI Medical Imaging Software for Cardiovascular Disease Market Size, by Machine Learning, 2017-2032 (USD Million)
TABLE 245. BRICS AI Medical Imaging Software for Cardiovascular Disease Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 246. BRICS AI Medical Imaging Software for Cardiovascular Disease Market Size, by CT, 2017-2032 (USD Million)
TABLE 247. BRICS AI Medical Imaging Software for Cardiovascular Disease Market Size, by Echocardiography, 2017-2032 (USD Million)
TABLE 248. BRICS AI Medical Imaging Software for Cardiovascular Disease Market Size, by MRI, 2017-2032 (USD Million)
TABLE 249. BRICS AI Medical Imaging Software for Cardiovascular Disease Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 250. BRICS AI Medical Imaging Software for Cardiovascular Disease Market Size, by Cloud, 2017-2032 (USD Million)
TABLE 251. BRICS AI Medical Imaging Software for Cardiovascular Disease Market Size, by On Premise, 2017-2032 (USD Million)
TABLE 252. BRICS AI Medical Imaging Software for Cardiovascular Disease Market Size, by Application, 2017-2032 (USD Million)
TABLE 253. BRICS AI Medical Imaging Software for Cardiovascular Disease Market Size, by End User, 2017-2032 (USD Million)
TABLE 254. G7 AI Medical Imaging Software for Cardiovascular Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 255. G7 AI Medical Imaging Software for Cardiovascular Disease Market Size, by Technology, 2017-2032 (USD Million)
TABLE 256. G7 AI Medical Imaging Software for Cardiovascular Disease Market Size, by Deep Learning, 2017-2032 (USD Million)
TABLE 257. G7 AI Medical Imaging Software for Cardiovascular Disease Market Size, by Machine Learning, 2017-2032 (USD Million)
TABLE 258. G7 AI Medical Imaging Software for Cardiovascular Disease Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 259. G7 AI Medical Imaging Software for Cardiovascular Disease Market Size, by CT, 2017-2032 (USD Million)
TABLE 260. G7 AI Medical Imaging Software for Cardiovascular Disease Market Size, by Echocardiography, 2017-2032 (USD Million)
TABLE 261. G7 AI Medical Imaging Software for Cardiovascular Disease Market Size, by MRI, 2017-2032 (USD Million)
TABLE 262. G7 AI Medical Imaging Software for Cardiovascular Disease Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 263. G7 AI Medical Imaging Software for Cardiovascular Disease Market Size, by Cloud, 2017-2032 (USD Million)
TABLE 264. G7 AI Medical Imaging Software for Cardiovascular Disease Market Size, by On Premise, 2017-2032 (USD Million)
TABLE 265. G7 AI Medical Imaging Software for Cardiovascular Disease Market Size, by Application, 2017-2032 (USD Million)
TABLE 266. G7 AI Medical Imaging Software for Cardiovascular Disease Market Size, by End User, 2017-2032 (USD Million)
TABLE 267. NATO AI Medical Imaging Software for Cardiovascular Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 268. NATO AI Medical Imaging Software for Cardiovascular Disease Market Size, by Technology, 2017-2032 (USD Million)
TABLE 269. NATO AI Medical Imaging Software for Cardiovascular Disease Market Size, by Deep Learning, 2017-2032 (USD Million)
TABLE 270. NATO AI Medical Imaging Software for Cardiovascular Disease Market Size, by Machine Learning, 2017-2032 (USD Million)
TABLE 271. NATO AI Medical Imaging Software for Cardiovascular Disease Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 272. NATO AI Medical Imaging Software for Cardiovascular Disease Market Size, by CT, 2017-2032 (USD Million)
TABLE 273. NATO AI Medical Imaging Software for Cardiovascular Disease Market Size, by Echocardiography, 2017-2032 (USD Million)
TABLE 274. NATO AI Medical Imaging Software for Cardiovascular Disease Market Size, by MRI, 2017-2032 (USD Million)
TABLE 275. NATO AI Medical Imaging Software for Cardiovascular Disease Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 276. NATO AI Medical Imaging Software for Cardiovascular Disease Market Size, by Cloud, 2017-2032 (USD Million)
TABLE 277. NATO AI Medical Imaging Software for Cardiovascular Disease Market Size, by On Premise, 2017-2032 (USD Million)
TABLE 278. NATO AI Medical Imaging Software for Cardiovascular Disease Market Size, by Application, 2017-2032 (USD Million)
TABLE 279. NATO AI Medical Imaging Software for Cardiovascular Disease Market Size, by End User, 2017-2032 (USD Million)
TABLE 280. Global AI Medical Imaging Software for Cardiovascular Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 281. United States AI Medical Imaging Software for Cardiovascular Disease Market Size, 2017-2032 (USD Million)
TABLE 282. United States AI Medical Imaging Software for Cardiovascular Disease Market Size, by Technology, 2017-2032 (USD Million)
TABLE 283. United States AI Medical Imaging Software for Cardiovascular Disease Market Size, by Deep Learning, 2017-2032 (USD Million)
TABLE 284. United States AI Medical Imaging Software for Cardiovascular Disease Market Size, by Machine Learning, 2017-2032 (USD Million)
TABLE 285. United States AI Medical Imaging Software for Cardiovascular Disease Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 286. United States AI Medical Imaging Software for Cardiovascular Disease Market Size, by CT, 2017-2032 (USD Million)
TABLE 287. United States AI Medical Imaging Software for Cardiovascular Disease Market Size, by Echocardiography, 2017-2032 (USD Million)
TABLE 288. United States AI Medical Imaging Software for Cardiovascular Disease Market Size, by MRI, 2017-2032 (USD Million)
TABLE 289. United States AI Medical Imaging Software for Cardiovascular Disease Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 290. United States AI Medical Imaging Software for Cardiovascular Disease Market Size, by Cloud, 2017-2032 (USD Million)
TABLE 291. United States AI Medical Imaging Software for Cardiovascular Disease Market Size, by On Premise, 2017-2032 (USD Million)
TABLE 292. United States AI Medical Imaging Software for Cardiovascular Disease Market Size, by Application, 2017-2032 (USD Million)
TABLE 293. United States AI Medical Imaging Software for Cardiovascular Disease Market Size, by End User, 2017-2032 (USD Million)
TABLE 294. Canada AI Medical Imaging Software for Cardiovascular Disease Market Size, 2017-2032 (USD Million)
TABLE 295. Canada AI Medical Imaging Software for Cardiovascular Disease Market Size, by Technology, 2017-2032 (USD Million)
TABLE 296. Canada AI Medical Imaging Software for Cardiovascular Disease Market Size, by Deep Learning, 2017-2032 (USD Million)
TABLE 297. Canada AI Medical Imaging Software for Cardiovascular Disease Market Size, by Machine Learning, 2017-2032 (USD Million)
TABLE 298. Canada AI Medical Imaging Software for Cardiovascular Disease Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 299. Canada AI Medical Imaging Software for Cardiovascular Disease Market Size, by CT, 2017-2032 (USD Million)
TABLE 300. Canada AI Medical Imaging Software for Cardiovascular Disease Market Size, by Echocardiography, 2017-2032 (USD Million)
TABLE 301. Canada AI

Companies Mentioned

  • Aidoc Medical Ltd.
  • Arterys, Inc.
  • Canon Medical Systems Corporation
  • CureMetrix Inc.
  • Densitas Inc.
  • eCure Corp.
  • GE HealthCare Technologies Inc.
  • HeartFlow, Inc.
  • Koninklijke Philips N.V.
  • LifeBlood Analytics Ltd.
  • Lunit Inc.
  • Medis Medical Imaging Systems B.V.
  • Quibim SL
  • Qure.ai Technologies Pvt. Ltd.
  • Siemens Healthineers AG
  • Ultromics Ltd.
  • VIDA Diagnostics, Inc.
  • Viz.ai, Inc.
  • Zebra Medical Vision Ltd.

Related Topics

Related Reports

AI Medical Imaging Software for Coronary CT Angiography Market - Global Forecast 2026-2032 - Product Image

AI Medical Imaging Software for Coronary CT Angiography Market - Global Forecast 2026-2032

  • Report
  • 185 Pages
  • Global
From
Cardiac Imaging Software - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Cardiac Imaging Software - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 185 Pages
  • Global
From
AI Medical Imaging Software for Cerebrovascular Diseases Market - Global Forecast 2026-2032 - Product Image

AI Medical Imaging Software for Cerebrovascular Diseases Market - Global Forecast 2026-2032

  • Report
  • 198 Pages
  • Global
From
Medical Imaging Software - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Medical Imaging Software - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 157 Pages
  • Global
From
Medical X-Ray Equipment and Imaging Software Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Image

Medical X-Ray Equipment and Imaging Software Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.